Dr Palmero holds a Bachelor's degree in Biological Sciences from the Federal University of Santa Maria, a Master's and PhD in Genetics and Molecular Biology from the Federal University of Rio Grande do Sul. She completed herr first postdoctoral fellowship at the National Centre for Biomedical Engineering Science in Galway, Ireland. Her second postdoctoral fellowship was carried out at the International Agency for Research on Cancer (IARC) in Lyon, France. She is a CNPq productivity researcher and a member (management committee) of the Brazilian Hereditary Cancer Network - REBRACH and LA-GETH. She is a professor-researcher at the National Cancer Institute (INCA), where she is a Permanent Faculty of the Graduate Program in Oncology and a Deputy Coordinator of the aforementioned Graduate Program. She is a collaborating faculty member at the Center for Research in Molecular Oncology/Graduate Program in Oncology of the Barretos Cancer Hospital. She was awarded with the Saúde Abril Health Award in the Men's and Women's Health category for her work in identifying women at risk for hereditary cancer in the general population.She has expertise in the field of Genetics and Cancer, with an emphasis on Hereditary Cancer. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Breast cancer (BC) is considered a public health problem, being 5% to 10% hereditary. The identification of individuals at risk for hereditary cancer is important because: 1) affected individuals have a much higher cumulative cancer risk, 2) relatives of an affected individual may be at-risk for hereditary cancer, and 3) the existence of intensive screening and preventive intervention me…
Gastric cancer is a very aggressive pathology that still with a frightening prognosis. Despite the decrease of the incidence, the gastric cancer remains as one of the most deadly diseases, being the fourth most diagnosed cancer and the second most deadly cancer in the world. Somatic mutation in the TP53 gene are frequently in gastric tumors. However, the frequency of germline mutations of…
Breast cancer is the more frequent tumor type in women, about 5-10% of the cases are hereditary. The main genes associated with a higher breast cancer predisposition are BRCA1, BRCA2, TP53, PTEN, CDH1, STK11 and, more recently, PALB2, a tumor suppressor gene involved in several cellular functions, mainly in the DNA Double-Strand Break (DSB) repair. The genetic variants found in these gene…
It is known that breast and ovarian tumors with germline mutations in BRCA1 or BRCA2 genes are up to 1000 times more sensitive to treatment with PARP inhibitors than wild type tumors. Although, little is known about the effect of these PARP inhibitors on tumors harboring mutations in other genes involved in the homologous recombination mechanism of DNA repair. The objective of this work i…
(Only some records are available in English at this moment)
Programmed Death 1 (PD-1) and T cell Ig and mucin domain-3 protein (Tim-3) are immune checkpoint receptors that are expressed on tumor-infiltrating lymphocytes (TIL) in tumor-bearing mice and humans. As anti-PD-1 single agent response rates are only <20% in head and neck squamous cell carcinoma (HNSCC) patients, it is important to understand how multiple inhibitory checkpoint receptors ma…
| 1 / 1 | Completed research grants |
| 12 / 7 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 14 / 9 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID